At A Glance
Healthcare marketers are spending record amounts on pharma advertising, but most still can't connect campaign exposure to prescribing outcomes. This article explains why fragmented data, identity, and measurement systems break the link between patient (DTC) and healthcare professional (HCP) audiences, and the infrastructure that closes that gap.Originally published in AdExchanger
Key takeaways
- Pharma digital ad spend is tracking between $22 billion and $26 billion in 2026, yet most brands still can’t connect ad exposure to prescribing behavior.
- DTC and HCP teams need to agree on a shared measurement framework before a campaign launches, not after, so performance can be judged on one standard.
- Experian’s identity infrastructure keeps DTC and HCP data governed separately through two distinct paths while still making cross-audience measurement possible.
- Experian’s Audience Engine connects audience building to activation, giving teams access to premium publisher inventory and a marketplace of 19+ verified health data partners.
Healthcare marketing teams are spending more than ever. Pharma digital ad spend is now tracking between $22 billion and $26 billion in 2026, with connected TV (CTV) overtaking search as the most noticed healthcare ad channel. Yet most brands still can’t draw a straight line from campaign exposure to a filled prescription.
The problem isn’t budget or creative. It’s a structural gap in how healthcare marketers connect data, identity, and measurement across patient (DTC) and healthcare professional (HCP) audiences.
That gap is widening as campaigns grow more complex. A brand running a simultaneous patient (DTC) push and healthcare professional (HCP) engagement program is running two disconnected programs with different data sources, identity schemas, agency relationships, and definitions of success. When a patient sees a CTV ad and their cardiologist receives a targeted digital engagement the same week, almost no brand can confirm that those two exposures happened, let alone measure their combined effect on prescribing behavior.
Why is data fragmentation becoming a bigger challenge for healthcare marketers?
Data fragmentation is becoming a bigger challenge for healthcare marketers because the accuracy pharma brands are paying for in digital media doesn’t match what most measurement stacks can deliver. As pharma shifts spend from linear television to digital channels, the expectation of accuracy comes with it. Brands can no longer accept “we reached the right demographic” as a measurement answer when they are paying programmatic CPMs and expecting outcomes measured in script lift.
The typical healthcare marketer is working with three or four disconnected data environments. Consumer data lives in one place. Claims and National Provider Identifier (NPI) records live in another. Media reporting from the agency is in a third. Analytics and measurement are downstream of all of them, often running on a different timeline. Each handoff introduces the potential for data loss, and those losses compound across a campaign flight.
This creates a reporting picture that tells you what happened in each channel but not what worked across them. That distinction matters enormously when the goal isn’t impressions but activation, adherence, or prescribing behavior.
The missing layer in pharma marketing. Watch our Q&A
Does fixing healthcare data fragmentation mean merging DTC and HCP data together?
No, merging DTC and HCP data together isn’t the answer to healthcare data fragmentation. Healthcare data environments have strict governance requirements, and the separation of DTC and HCP data is both a regulatory and a strategic necessity. Merging DTC and HCP data into a single undifferentiated pool is not a goal worth pursuing.
What healthcare marketers actually need is a shared infrastructure that lets disparate data environments speak a common language without eliminating the boundaries between them. Three elements make that possible:
Experian’s identity infrastructure is built on this principle, acting as a neutral, interoperable workflow layer. For DTC audiences, that means high-fidelity tokenized matching that preserves accuracy from onboarding through activation and into partner-enabled measurement. For HCP audiences, it means deterministic NPI-based resolution using verified professional attributes including specialty, practice location, and professional address. These are two distinct identity paths, governed to keep DTC and HCP data separate while enabling measurement across both.
From onboarding to outcomes
Pharma marketing teams need identity workflows that can support accurate audience creation, governed activation, and partner-enabled measurement without combining DTC and HCP identity paths.
Download our pharma marketing playbook to help your team:
- Plan DTC and HCP identity strategies with clearer separation
- Prepare audiences for activation across approved channels and partners
- Evaluate audience quality, usable reach, and governance
What does a connected view of DTC and HCP audiences look like in healthcare marketing?
A connected view means DTC and HCP audiences in healthcare marketing runs on identity workflows matched to what each requires, deterministic resolution for HCPs and high-fidelity matching for DTC, with both feeding into shared measurement instead of siloed reporting. Building this kind of connected infrastructure isn’t a one-quarter initiative, but three questions show you where your program stands today.
Why is infrastructure the foundation for durable healthcare marketing programs?
Infrastructure is the foundation for durable healthcare marketing programs because it’s what lets audience planning, activation, and measurement function as one connected system instead of three separate handoffs that break down under pressure. As healthcare marketing gets more competitive, regulated, and measurable, that connected system is what keeps campaigns from starting over each time.
A connected view of DTC and HCP audiences in healthcare, with the proper guardrails in place, is a strategic decision about how your brand wants to compete. The technology and the partner ecosystem exist to make it real. The question is whether your marketing organization is structured to take advantage of it.
Ready to build a connected healthcare identity strategy?
Our team works with pharma brands to align identity, audience, and measurement across DTC and HCP programs. If you’re ready to close the gap between data and outcomes, let’s talk.
About the author
Kevin Dunn
Chief Revenue Officer, Experian
Kevin Dunn joins Experian Marketing Services with more than 20 years of leadership experience across marketing and advertising technology, most recently serving as Senior Vice President of Brands and Agencies at LiveRamp. In that role, he led growth across retail, CPG, travel, hospitality, financial services, and healthcare, overseeing new business, account expansion, and channel partnerships.
Kevin is known for building cohesive, accountable teams and leading with optimism, clarity, and a strong sense of shared purpose. His leadership philosophy centers on empowering people, driving positive outcomes for clients and fostering a culture where teams can grow, take smart risks, and succeed together.
FAQs
Most pharma brands can’t connect a CTV ad exposure to a prescribing decision because their DTC and HCP data runs through three or four disconnected environments: consumer data, claims and NPI records, agency media reporting, and downstream analytics. Each handoff between those systems introduces potential data loss, and those losses add up across a campaign flight, leaving brands with channel-level reporting instead of a connected view of what actually moved prescribing behavior.
Building a connected identity strategy doesn’t mean combining DTC and HCP data into one data set. Healthcare data environments carry strict governance requirements, so DTC and HCP data need to stay separate for both regulatory and strategic reasons. A connected identity strategy links those separate environments through interoperable workflows rather than merging them into one data set.
Experian helps pharma brands connect DTC and HCP measurement without merging their data by running two distinct, governed identity paths: high-fidelity tokenized matching for DTC audiences and deterministic NPI-based resolution for HCP audiences, built on verified professional attributes like specialty and practice location. That structure lets brands measure performance across both audiences while keeping the underlying data separate.
The difference between deterministic and probabilistic matching in healthcare marketing comes down to certainty: probabilistic matching can support large-scale DTC reach where some statistical estimation is acceptable, while HCP targeting calls for certainty that only deterministic matching, typically based on verified NPI data, can provide. As healthcare audiences get more specific, the cost of an unverified match rises, which is why HCP resolution leans deterministic.
If a healthcare marketing team’s audience strategy isn’t translating into activation, the first thing to check is whether those audience segments can actually reach live publisher inventory. A lot of audience development happens in a spreadsheet or analytics tool and then stalls at activation because the IDs never connect to real media. Experian’s Audience Engine builds audience creation, onboarding, and activation into one workflow, backed by a marketplace of 19+ verified health data partners.
Latest posts
Tapad, part of Experian, integrates with AcuityAds’ current offering will complement cross-channel capabilities for brands and agencies in the U.S. and Canada NEW YORK, Jan. 23, 2020 /PRNewswire/ — Tapad, a global leader in digital identity resolution, has partnered with AcuityAds, a technology leader that provides targeted digital media solutions for advertisers to connect intelligently with audiences. The partnership will enhance AcuityAds’ existing cross-device solution, especially with respect to its cross-channel Connected TV offering. Tapad’s global, privacy-safe digital cross-device solution, The Tapad Graph, will compliment AcuityAds’ own cross-device data set for enhanced marketing capabilities across their Demand Side Platform (DSP). For AcuityAds, this provides customers with unduplicated reach across desktop, tablet, mobile and CTV devices – while augmenting their video offering. Tom Woods, Vice President of Products at AcuityAds commented, “With increasing marketing complexities, consumer device usage and new data regulations, our decision regarding the partnership was an important one. The Tapad Graph’s privacy-safe identifiers for consumer notice and choice, as well as the ability to opt-out at any point, were critical factors in our decision who to partner with.” To learn more about Tapad and our digital identity resolution capabilities, visit our identity page. About Tapad Tapad, Inc. is a global leader in digital identity resolution. The Tapad Graph and its related solutions provide a transparent, privacy-safe approach connecting brands to consumers through their devices globally. Tapad is recognized across the industry for its product innovation, workplace culture, and talent, and has earned numerous awards including One World Identity’s 2019 Top 100 Influencers in Identity Award. Headquartered in New York, Tapad also has offices in Chicago, London, Oslo, Singapore, and Tokyo. About AcuityAds AcuityAds is a leading technology company that provides marketers a powerful and holistic solution for digital advertising across all ad formats and screens to amplify reach and Share of Attention® throughout the customer journey. Via its unique, data-driven insights, real-time analytics and industry-leading activation platform based on proprietary Artificial Intelligence technology, AcuityAds leverages an integrated ecosystem of partners for data, inventory, brand safety and fraud prevention, offering unparalleled, trusted solutions that the most demanding marketers require to be successful in the digital era. AcuityAds is headquartered in Toronto with offices throughout the U.S., Europe and Latin America. For more information, visit AcuityAds.com. Disclaimer in regards to Forward-looking Statements Certain statements included herein constitute “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at this time, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Investors are cautioned not to put undue reliance on forward-looking statements. Except as required by law, AcuityAds does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events. Contact us today
Tapad, a part of Experian and the future of cookies Earlier this week, Google announced plans to create “.. a path towards making third-party cookies obsolete”; which will result in the phasing out of support for third-party cookies in its Chrome browser within two years. While there has been much discussion and debate on the future of the third-party cookie, an announcement from Google has been anticipated for some time. As many have said this week, the use of cookies and other identifiers has and will continue to evolve. What will never change is the value exchange between publishers and consumers that is enabled by relevant advertising. Notably, the need for independent companies to develop solutions that enable this value exchange has never been greater to ensure that publishers, consumers, and advertisers derive the most value from their relationship. We are well-positioned for the future From the start, Tapad, a part of Experian has led with a consumer-first, privacy-centric approach to technology as the use and proliferation of devices and global privacy regulations continue to evolve. Over the past two years, Tapad, a part of Experian has gone through a technical overhaul. Calling on almost ten years of expertise in identity resolution, we have created a modern platform that is flexible in terms of identity input as well as output. Anticipated change in the identity landscape was the driver behind our architecture decisions and what enables us to be responsive to a dynamic market. Consumer behavior and device use continue to change, bringing additional digital IDs into the equation – namely across the mobile and CTV environments. Our technology, however, is not tied to any specific type of identifier, but rather is focused on associating disparate identifiers at the individual and household level. Where do we go from here? Google’s announcement has been characterized as a conversation starter, but we see it more as a call to action. With a timeline set, there is a need to converge on one or more solutions that can scale across the web. In a post cookie world, publishers and advertisers will continue to require ways to create fair marketplaces across platforms and devices. Further, the platforms that currently power the programmatic advertising ecosystem will need to be able to invest and differentiate to bring value to their customers. Scaled privacy-safe identity solutions will be needed not only for classic targeting, attribution, measurement, and frequency capping use cases but also to carry consumer preferences and consent. Tapad, a part of Experian will continue to play a leading role here. However, we are not going to do this alone. As solutions around Google’s Chrome browser evolve, we will continue to take a leadership position and will work with Google, key industry groups, partners and customers to meet current and future needs for an independent identity solution at scale. In the meantime, we will continue to support an independent ecosystem where consumers come first and privacy standards are a priority. It’s business as usual…for now. There will not be any changes to our graph products or services as a result of Google’s announcement in the near term. Any changes related to the Chrome third-party cookie will evolve and will no doubt be subject to significant industry participation and feed-back, indeed at the invitation of Google. We will proactively communicate any changes and product updates during this time period. We look forward to the opportunities resulting from these changes and ushering in a new era of identity resolution in digital advertising. Contact us today
Tapad’s integration with Knorex’s XPO™ platform will complement cross-channel optimization capabilities for brands and agencies in the U.S. and APAC markets NEW YORK and SINGAPORE, Dec. 10, 2019 /PRNewswire/ — Tapad, part of Experian and a global leader in digital identity resolution, has partnered with Knorex, a leading provider of digital performance marketing. Knorex’s self-service online advertising platform, Knorex XPO™, enables marketers to advertise globally in real-time across different media channels, formats, platforms and devices. Tapad’s global, privacy-safe digital cross-device solution, The Tapad Graph, will compliment Knorex XPO™’s own device data set for enhanced marketing capabilities. For Knorex, the integration enables their brand direct and agency customers to gain a more accurate understanding of consumers across devices to reduce campaign inefficiencies and duplication, and to effectively manage frequency capping and attribution. Abhishek Kumar, VP of Engineering at Knorex commented, “Today’s digital consumer is raising the bar for marketers. With increasing marketing complexities and consumer device usage, this integration enables marketers to understand the consumer decision journey with heightened ease. Our combined offering will empower agencies in the APAC and US markets, providing an improved marketing solution that will help to streamline their efforts.” Abhay Doshi, Head of APAC at Tapad added: “The Tapad Graph, when integrated with the Knorex XPO platform, should not only help U.S. and APAC marketers optimize campaign performance through cross device marketing – but also increase the opportunity for brands to reach out to their target customers within a desired time.” To learn more about Tapad and our digital identity resolution capabilities, visit https://www.experian.com/marketing/consumer-sync. About TapadTapad, Inc. is a global leader in digital identity resolution. The Tapad Graph and its related solutions provide a transparent, privacy-safe approach connecting brands to consumers through their devices globally. Tapad is recognized across the industry for its product innovation, workplace culture, and talent, and has earned numerous awards including One World Identity’s 2019 Top 100 Influencers in Identity Award. Headquartered in New York, Tapad also has offices in Chicago, London, Oslo, Singapore, and Tokyo. About KnorexKnorex provides programmatic advertising products and technologies to advertising buyers worldwide. With its cloud-based online advertising platform, Knorex XPO™ enables ad buyers to self-serve and advertise real-time across the globe regardless of the media channels (social, search, OTT/CTV, video, web/mobile etc.), ad formats (display, native, search, social, video etc) and devices (desktop, laptop, smartphones and tablets) to deliver personalized marketing messages to the target audience in an automated way, powered by machine learning/AI. Underpinned by a multi-layered data-driven approach, XPO simplifies the execution and optimization of marketing campaigns, while delivering measurable and attributable performance. Contact us today